Tulaton Sodsri

Dr. Tulaton Sodsri

Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samut Prakan, Thailand
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Tulaton SodsriTulaton Sodsri
Tulaton Sodsri
TPTananchai Petnak
Tananchai Petnak
PNPintip Ngamjanyaporn
Pintip Ngamjanyaporn
Anti-synthetase syndrome (ASS) is a rare autoimmune disease. Since the knowledge of ASS remains limited, we conducted the retrospective study aiming to describe clinical characteristics and identify variables associated with interstitial lung disease (ILD) and mortality among patients with ASS. Patients diagnosed with ASS from January 2013 to October 2022 were included. Patient demographics, clinical manifestations, myositis auto-antibody profiles, HRCT findings, and laboratory tests were collected. Variables associated with mortality risk and ILD were evaluated using the Cox proportional hazards model and the logistic regression model, respectively. A total of 82 patients with ASS were included. Clinical manifestations included arthritis (57%), Raynaud’s phenomenon (32%), mechanic’s hands (29%), fever (26%), and myositis (17%). The myositis auto-antibody profiles included anti-PL-7 (29%), anti-Jo-1 (27%), anti-EJ (17%), anti-PL-12 (16%), and anti-OJ (11%). ILD was observed in 64 patients (78%). Among patients with ILD, 21 initially presented with ILD before developing other ASS clinical manifestations, 29 simultaneously presented with ILD and other symptoms, and 14 had isolated ILD throughout follow-up. Overall, 6 patients presented with rapid-progressive ILD. With a median follow-up time of 2.5 years, mortality was observed in 10 patients (12.2%). Factors associated with mortality included increased lymphocyte counts (adjusted HR, 0.74; 95% CI, 0.61–0.91; p < 0.01), isolated ILD (adjusted HR, 9.59; 95% CI, 1.52–60.61; p = 0.02) and the presence of anti-Ro52 antibodies (adjusted HR, 0.14; 95% CI, 0.02–0.93; p = 0.04). Factors associated with ILD included age (adjusted OR, 1.10; 95% CI, 1.03–1.18; p = 0.01), presence of anti-Ro52 antibodies (adjusted OR, 17.92; 95% CI, 2.13–138.68; p = 0.01), and presence of arthritis (adjusted OR, 0.09; 95% CI, 0.01–0.75; p = 0.03). Our study demonstrated a favorable overall mortality rate among ASS patients.

28 March 2025 in Journal of Gastrointestinal and Liver Diseases
Verified
Journal Article
Open access
PDF file
TSThanathip Suenghataiphorn
Thanathip Suenghataiphorn
NXNutchapon Xanthavanij
Nutchapon Xanthavanij
Panat YanpisetPanat Yanpiset
Panat Yanpiset
TSThitiphan Srikulmontri
Thitiphan Srikulmontri
BTBen Thiravetyan
Ben Thiravetyan
PWPhuuwadith Wattanachayakul
Phuuwadith Wattanachayakul
Background and Aims: Constipation is commonly seen among patients with cardiovascular diseases and is linked to adverse outcomes. However, the association between constipation and the risk of acute myocardial infarction (AMI) remains conflicting. Therefore, we aimed to conduct a systematic review and meta-analysis to summarize the available data on this topic. Method: We identified potentially eligible studies from the MEDLINE and EMBASE databases, searching from inception to May 2024, to investigate the association between constipation and the risk of developing AMI. To be included, studies needed to compare incidence of AMI between cohorts with and without constipation. Effect size and 95% confidence intervals (CIs) were combined using the generic inverse variance method. All statistical analyses were performed by Review Manager 5.4. Results: Our meta-analysis included seven studies that met the eligibility criteria. There were 5,351,976 participants, with a mean age of 57.8 years and 74% were males. We found that patients with constipation had a 14% increased risk of AMI with a pooled risk ratio (RR) of 1.14 (95%CI: 1.08-1.14; I²=85%; p<0.001) compared to those without constipation. Conclusions: Our study revealed that constipation is associated with a higher risk of AMI. Emphasizing and addressing gastrointestinal health, including constipation, as an important issue is essential for comprehensive cardiovascular care.

1 July 2025 in Journal of Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
NCNattanicha Chaisrimaneepan
Nattanicha Chaisrimaneepan
TKThunyaporn Khoruamklang
Thunyaporn Khoruamklang
Tulaton SodsriTulaton Sodsri
Tulaton Sodsri
NJNatnicha Jakramonpreeya
Natnicha Jakramonpreeya
Nattanicha Chaisrimaneepan, M.D., Thunyaporn Khoruamklang, M.D., Tulaton Sodsri, M.D., Natnicha Jakramonpreeya, M.D.. J Rheum Dis -0001;0:. https://doi.org/10.4078/jrd.2025.0035

9 November 2026 in Seminars in Arthritis and Rheumatism
Verified
Journal Article
Closed access
Tulaton SodsriTulaton Sodsri
Tulaton Sodsri
NCNattanicha Chaisrimaneepan
Nattanicha Chaisrimaneepan
BTBen Thiravetyan
Ben Thiravetyan
RBRabhas Boonyawairote
Rabhas Boonyawairote
NMNopavit Mohpichai
Nopavit Mohpichai
TPTananchai Petnak
Tananchai Petnak

23 October 2025 in The Southwest Journal of Medicine
Verified
Journal Article
Open access
PDF file
BTBen Thiravetyan
Ben Thiravetyan
Tulaton SodsriTulaton Sodsri
Tulaton Sodsri
CPChanokporn Puchongmart
Chanokporn Puchongmart
JNJacob Nichols
Jacob Nichols
Odynophagia is a common complaint among individuals living with HIV, with candidiasis being the predominant cause. We present a case of 38-year-old man with poorly controlled HIV who presented with odynophagia and oropharyngeal candidiasis that is refractory to antifungal therapy. Further investigations showed esophageal candidiasis with esophageal ulcers, which pathology revealed extensive filamentous bacteria in addition to fungal hyphae. Diagnosis of esophageal candidiasis superimposed with actinomycosis was made, and he responded well to amoxicillin in addition to fluconazole therapy.Keywords: Esophageal actinomycosis, Actinomycosis, Actinomyces, HIV